With 0.83 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.14 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $1.78 whereas the lowest price it dropped to was $1.45. The 52-week range on SXTC shows that it touched its highest point at $7.84 and its lowest point at $0.95 during that stretch. Beta for the stock currently stands at 1.40.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SXTC was up-trending over the past week, with a rise of 5.07%, but this was up by 11.54% over a month. Three-month performance dropped to -22.46% while six-month performance fell -16.18%. The stock lost -64.33% in the past year, while it has lost -57.20% so far this year.
Float and Shares Shorts:
At present, 116.03 million SXTC shares are outstanding with a float of 75.04 million shares on hand for trading. On 2025-11-28, short shares totaled 0.18 million, which was 15.0 higher than short shares on 1761868800. In addition to Mr. Feng Zhou as the firm’s Chairman of the Board & Co-CEO, Mr. Sze Beng Lim serves as its Co-Chief Executive Officer.
